{"id":838021,"date":"2025-04-16T08:41:07","date_gmt":"2025-04-16T12:41:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/"},"modified":"2025-04-16T08:41:07","modified_gmt":"2025-04-16T12:41:07","slug":"vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/","title":{"rendered":"Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company"},"content":{"rendered":"
\n

\n
\n Portfolio of miniature, once or twice-yearly GLP-1 implants in development for chronic weight management and type 2 diabetes<\/em>
\n <\/strong>\n <\/p>\n

\n
\n Vivani CEO Adam Mendelsohn, Ph.D. and CMO Lisa Porter, M.D. to discuss the Company\u2019s LIBERATE-1 clinical trial from which topline data is anticipated in mid-year 2025<\/em>
\n <\/strong>\n <\/p>\n

ALAMEDA, Calif., April 16, 2025 (GLOBE NEWSWIRE) — Vivani Medical, Inc.<\/a> (<\/strong>NASDAQ: VANI<\/a>)<\/strong> (\u201cVivani\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced its participation in a virtual fireside chat hosted by Yi Chen, Ph.D., CFA, Managing Director of Equity Research at H.C. Wainwright & Company.<\/p>\n

As part of the presentation, Vivani CEO Adam Mendelsohn, Ph.D. and CMO Lisa Porter, M.D., will discuss Vivani\u2019s LIBERATE-1 clinical trial. LIBERATE-1 is a first-in-human study of NPM-115, the Company\u2019s miniature, twice-yearly GLP-1 (exenatide) implant under development for chronic weight management. Vivani anticipates topline data for LIBERATE-1 in mid-year 2025.<\/p>\n

Details for viewing the fireside chat are as follows:<\/p>\n\n\n\n\n\n
Date:<\/td>\nThursday, April 24, 2025<\/td>\n<\/tr>\n
Time:<\/td>\n10 a.m. Eastern Time<\/td>\n<\/tr>\n
Weblink:<\/td>\n\n https:\/\/journey.ct.events\/view\/8202e32e-0026-417c-8e44-10a1503a831c<\/a>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/table>\n

\n About Vivani Medical, Inc.<\/strong>\n <\/p>\n

Leveraging its proprietary NanoPortal platform, Vivani develops therapeutic implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and potentially to improve patient tolerance to their medication. Vivani\u2019s lead programs, NPM-139 (semaglutide implant) and NPM-115 (exenatide implant), are miniature, subdermal GLP-1 implants under development for chronic weight management in obese or overweight individuals designed for once or twice-yearly administration. Vivani\u2019s emerging pipeline also includes NPM-119, which refers to the Company\u2019s six-month, subdermal, GLP-1 (exenatide implant) under development for the treatment of type 2 diabetes. Development of a semaglutide implant for the treatment of type 2 diabetes is also under consideration. These NanoPortal implants are designed to provide patients with the opportunity to experience the full potential benefit of their medication by avoiding the challenges associated with the daily or weekly administration of oral and injectable medications.<\/p>\n

Medication non-adherence occurs when patients do not take their medication as prescribed. This affects an alarming number of patients, approximately 50%, including those taking daily pills. Medication non-adherence, which contributes to more than $500 billion in annual avoidable healthcare costs and 125,000 potentially preventable deaths annually in the U.S. alone, is a primary and daunting reason why obese or overweight patients, and patients taking type 2 diabetes or other chronic disease treatments, face significant challenges in achieving positive real-world effectiveness. While the current GLP-1 landscape includes over 50 new molecular entities under clinical stage development, Vivani remains confident that its highly differentiated portfolio of miniature, ultra long-acting GLP-1 implants have the potential to provide an attractive therapeutic option for patients, prescribers and payers. For more information, please visit:\u00a0www.vivani.com<\/a>.<\/p>\n

\n Forward-Looking Statements<\/strong>\n <\/p>\n

This press release contains certain \u201cforward-looking statements\u201d within the meaning of the \u201csafe harbor\u201d provisions of the US Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: \u201ctarget,\u201d \u201cbelieve,\u201d \u201cexpect,\u201d \u201cwill,\u201d \u201cmay,\u201d \u201canticipate,\u201d \u201cestimate,\u201d \u201cwould,\u201d \u201cpositioned,\u201d \u201cfuture,\u201d and other similar expressions that in this press release, including statements regarding Vivani\u2019s business, products in development, including the therapeutic potential thereof, the planned development therefor, the completion of the LIBERATE-1 trial and reporting of trial results, Vivani\u2019s emerging development plans for NPM-115, NPM-139, NPM-119, and Vivani\u2019s technology, strategy, cash position and financial runway. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on Vivani\u2019s current beliefs, expectations, and assumptions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Vivani\u2019s control. Actual results and outcomes may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause actual results and outcomes to differ materially from those indicated in the forward-looking statements include, among others, risks related to the development and commercialization of Vivani\u2019s products, including NPM-115, NPM-139, and NPM-119; delays and changes in the development of Vivani\u2019s products, including as a result of applicable laws, regulations and guidelines, potential delays in submitting and receiving regulatory clearance or approval to conduct Vivani\u2019s development activities; risks related to the initiation, enrollment and conduct of Vivani\u2019s planned clinical trials and the results therefrom; Vivani\u2019s history of losses and Vivani\u2019s ability to access additional capital or otherwise fund Vivani\u2019s business; market conditions and the ability of Cortigent to complete its intended spin-off from the Company. There may be additional risks that the Company considers immaterial, or which are unknown. A further list and description of risks and uncertainties can be found in the Company\u2019s most recent Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission filed on March 31, 2025, as updated by the Company\u2019s subsequent Quarterly Reports on Form 10-Q. Any forward-looking statement made by Vivani in this press release is based only on information currently available to the Company and speaks only as of the date on which it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of added information, future developments or otherwise, except as required by law.<\/p>\n

Company Contact:
Donald Dwyer
Chief Business Officer
info@vivani.com
(415) 506-8462<\/p>\n

Investor Relations Contact:
Jami Taylor
Investor Relations Advisor
investors@vivani.com
(415) 506-8462<\/p>\n

Media Contact:
Sean Leous
ICR Healthcare
Sean.Leous@ICRHealthcare.com
(646) 866-4012<\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Portfolio of miniature, once or twice-yearly GLP-1 implants in development for chronic weight management and type 2 diabetes Vivani CEO Adam Mendelsohn, Ph.D. and CMO Lisa Porter, M.D. to discuss the Company\u2019s LIBERATE-1 clinical trial from which topline data is anticipated in mid-year 2025 ALAMEDA, Calif., April 16, 2025 (GLOBE NEWSWIRE) — Vivani Medical, Inc. (NASDAQ: VANI) (\u201cVivani\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced its participation in a virtual fireside chat hosted by Yi Chen, Ph.D., CFA, Managing Director of Equity Research at H.C. Wainwright & Company. As part of the presentation, Vivani CEO Adam Mendelsohn, Ph.D. and CMO Lisa Porter, M.D., will discuss Vivani\u2019s LIBERATE-1 clinical trial. LIBERATE-1 is a … <\/p>\n

Continue reading “Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-838021","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nVivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Portfolio of miniature, once or twice-yearly GLP-1 implants in development for chronic weight management and type 2 diabetes Vivani CEO Adam Mendelsohn, Ph.D. and CMO Lisa Porter, M.D. to discuss the Company\u2019s LIBERATE-1 clinical trial from which topline data is anticipated in mid-year 2025 ALAMEDA, Calif., April 16, 2025 (GLOBE NEWSWIRE) — Vivani Medical, Inc. (NASDAQ: VANI) (\u201cVivani\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced its participation in a virtual fireside chat hosted by Yi Chen, Ph.D., CFA, Managing Director of Equity Research at H.C. Wainwright & Company. As part of the presentation, Vivani CEO Adam Mendelsohn, Ph.D. and CMO Lisa Porter, M.D., will discuss Vivani\u2019s LIBERATE-1 clinical trial. LIBERATE-1 is a … Continue reading "Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-16T12:41:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzE4MyM2ODY4ODk5IzIyOTkzOTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company\",\"datePublished\":\"2025-04-16T12:41:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\\\/\"},\"wordCount\":943,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMzE4MyM2ODY4ODk5IzIyOTkzOTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\\\/\",\"name\":\"Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMzE4MyM2ODY4ODk5IzIyOTkzOTA=\",\"datePublished\":\"2025-04-16T12:41:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMzE4MyM2ODY4ODk5IzIyOTkzOTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQyMzE4MyM2ODY4ODk5IzIyOTkzOTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/","og_locale":"en_US","og_type":"article","og_title":"Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company - Market Newsdesk","og_description":"Portfolio of miniature, once or twice-yearly GLP-1 implants in development for chronic weight management and type 2 diabetes Vivani CEO Adam Mendelsohn, Ph.D. and CMO Lisa Porter, M.D. to discuss the Company\u2019s LIBERATE-1 clinical trial from which topline data is anticipated in mid-year 2025 ALAMEDA, Calif., April 16, 2025 (GLOBE NEWSWIRE) — Vivani Medical, Inc. (NASDAQ: VANI) (\u201cVivani\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, today announced its participation in a virtual fireside chat hosted by Yi Chen, Ph.D., CFA, Managing Director of Equity Research at H.C. Wainwright & Company. As part of the presentation, Vivani CEO Adam Mendelsohn, Ph.D. and CMO Lisa Porter, M.D., will discuss Vivani\u2019s LIBERATE-1 clinical trial. LIBERATE-1 is a … Continue reading \"Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-16T12:41:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzE4MyM2ODY4ODk5IzIyOTkzOTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company","datePublished":"2025-04-16T12:41:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/"},"wordCount":943,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzE4MyM2ODY4ODk5IzIyOTkzOTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/","name":"Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzE4MyM2ODY4ODk5IzIyOTkzOTA=","datePublished":"2025-04-16T12:41:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzE4MyM2ODY4ODk5IzIyOTkzOTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQyMzE4MyM2ODY4ODk5IzIyOTkzOTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vivani-medical-to-participate-in-virtual-fireside-chat-hosted-by-h-c-wainwright-company\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/838021","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=838021"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/838021\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=838021"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=838021"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=838021"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}